Last Updated:
Name Designation Appointment Date Status
Harbhajan Singh Girgla

Appointed as Director since April 2000

Director 06-Apr-2000 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Bhoopinder Jit Girgla

Appointed as Director since April 2000

Director 06-Apr-2000 Current
Harsh Preet Singh Girgla

Appointed as Director since April 2000

Director 06-Apr-2000 Current

People Timeline

Explore the timeline of key personnel in Girgla Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address 65-A Pratap Nagar Jail Road, New Delhi Delhi, 110004, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110004
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Girgla Pharmaceuticals Private Limited?
You can contact Girgla Pharmaceuticals Private Limited through their registered address at 65-A Pratap Nagar Jail Road, New Delhi Delhi, 110004, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Girgla Pharmaceuticals Private Limited?
The current directors of Girgla Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • HARBHAJAN SINGH GIRGLA
  • BHOOPINDER JIT GIRGLA
  • HARSH PREET SINGH GIRGLA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available